Genitourinary tuberculosis.
D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003523:Cycloserine / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D005000:Ethionamide / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006977:Hypertension, Renal / Q000209:etiology; D007538:Isoniazid / Q000009:adverse effects / Q000627:therapeutic use; D007612:Kanamycin / Q000627:therapeutic use; D008297:Male; D009392:Nephrectomy; D011736:Pyridoxine / Q000627:therapeutic use; D011859:Radiography; D012293:Rifampin / Q000627:therapeutic use; D014398:Tuberculosis, Renal / Q000150:complications / Q000000981:diagnostic imaging / Q000628:therapy; D014401:Tuberculosis, Urogenital / Q000453:epidemiology / Q000628:therapy / Q000652:urine; D014481:United States
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D007612:Kanamycin; D003523:Cycloserine; D011736:Pyridoxine; D005000:Ethionamide; D007538:Isoniazid; D012293:Rifampin